Abingworth as of June 30, 2013
Portfolio Holdings for Abingworth
Abingworth holds 11 positions in its portfolio as reported in the June 2013 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Amarin Corporation (AMRN) | 36.0 | $47M | 8.1M | 5.79 | |
| Portola Pharmaceuticals | 23.5 | $31M | 1.2M | 24.58 | |
| Supernus Pharmaceuticals (SUPN) | 17.8 | $23M | 3.6M | 6.44 | |
| Alnylam Pharmaceuticals (ALNY) | 7.5 | $9.7M | 313k | 30.95 | |
| OncoGenex Pharmaceuticals | 4.5 | $5.9M | 604k | 9.80 | |
| Cempra | 4.3 | $5.6M | 714k | 7.83 | |
| Zogenix | 3.1 | $4.0M | 2.3M | 1.72 | |
| Anthera Pharmaceuticals | 1.3 | $1.7M | 3.5M | 0.49 | |
| Hyperion Therapeutics | 1.1 | $1.4M | 63k | 22.02 | |
| Gw Pharmaceuticals Plc ads | 0.7 | $879k | 102k | 8.60 | |
| Zalicus | 0.2 | $270k | 474k | 0.57 |
